# Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma

> **NCT07504939** · — · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
- Upper Tract Urothelial Carcinoma

## Interventions

- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT07504939
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2030-04-01
- **Final completion:** 2030-04-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07504939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07504939, "Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT07504939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*